IPAMORELIN

Chemical Makeup:

• Chemical Name: Ipamorelin Acetate
• Molecular Formula: C38, H49, N9, O5
• Molecular Weight: 711.86 g/mol
• PubChem CID: 9831659
• Synonyms: NNC 26-0161, IPAM
• Solubility: Soluble in Water, Acetic Acid

Sequence: 

• Aib-His-D-2-Nal-D-Phe-Lys-NH2
  
  

Ipamorelin and Growth Hormone Selectivity

In comparative studies involving murine and porcine models, Ipamorelin has been observed to stimulate GH release in a dose-dependent manner. Research indicates that the peptide maintains efficacy over prolonged periods without inducing the rapid desensitization often seen with other non-selective agonists. Crucially, assays measuring plasma levels of ACTH and cortisol following administration found no significant elevation, suggesting that Ipamorelin does not activate the hypothalamic-pituitary-adrenal (HPA) axis to the same extent as earlier generations of GHRPs.

Ipamorelin and Bone Mineral Density

Experimental models involving adult female rats have been utilized to assess the impact of Ipamorelin on bone structure. In these studies, subjects treated with Ipamorelin demonstrated an increase in longitudinal bone growth rate (LGR) and bone mineral content (BMC). Researchers hypothesize that the peptide may influence osteoblast activity through the systemic elevation of Insulin-like Growth Factor 1 (IGF-1), a downstream effector of Growth Hormone.

Ipamorelin and Gastric Motility

While structurally similar to Ghrelin, Ipamorelin’s influence on gastric emptying has been a subject of specific investigation. In models of postoperative ileus (POI)—a condition characterized by a transient cessation of bowel motility—administration of Ipamorelin was observed to accelerate gastric emptying. It is suggested that this effect is mediated through the activation of cholinergic excitatory neurons in the enteric nervous system, independent of the central vagal pathways.

Ipamorelin and Nitrogen Balance

In catabolic states induced within animal test subjects (e.g., via corticosteroid administration), Ipamorelin has been studied for its potential to counteract muscle wasting. Data indicates that the peptide may improve nitrogen balance, shifting the metabolic state from catabolism to anabolism. This suggests a potential role in research related to sarcopenia and cachexia, where preservation of lean body mass is the primary variable of interest.

If you're not 100% satisfied within the first 30 days, just send it back to us and we'll give you a full refund.

No need to worry about the return shipping - we've got you covered!

We offer fast and reliable shipping on all orders. You can expect to receive it within 7-12 business days based on your location.

Please contact our customer service team for assistance if you have any questions or concerns about your shipment.

Adverse Events in Animal Models: 

In pre-clinical toxicology screenings using rodent models, Ipamorelin was generally well-tolerated. Minor adverse events noted in literature include localized injection site reactions and transient flushing. Unlike GHRP-6 and GHRP-2, Ipamorelin did not induce significant hyperphagia (excessive hunger) or elevated prolactin levels in standard dosages, mitigating concerns regarding gynecomastia-like side effects in test subjects.

Handling Precautions: 

This peptide is supplied as a lyophilized powder and requires reconstitution with bacteriostatic water or a sterile saline solution. It is hygroscopic and sensitive to heat; proper storage at -20°C is required to maintain stability.

Disclaimer:

This product is strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic use. The biological effects described above rely on data derived from in vitro and in vivo animal studies. Any reference to "benefits" refers strictly to observations made in non-human research contexts.